These data suggest that the CD8+ T cell response against MC38 tumours is dominated by recognition of the endogenous retroviral envelope protein, p15E, over the identified neoantigens, AdpgkR304M and Dpagt1V213L. The gene discussed is CD8A; the disease is neoplasm.